Safety and immunogenicity of live attenuated influenza reassortant H5 vaccine (phase I–II clinical trials)

Objective  Our studies aimed to evaluate in clinical trials the safety and immunogenicity of an H5 live influenza vaccine candidate obtained using classical reassortment techniques from a low pathogenicity avian influenza (LPAI) A/Duck/Potsdam/1402‐6/86(H5N2) virus and the cold‐adapted (ca) donor st...

Descripción completa

Detalles Bibliográficos
Autores principales: Rudenko, Larisa, Desheva, Julia, Korovkin, Sergey, Mironov, Alexander, Rekstin, Andrey, Grigorieva, Elena, Donina, Svetlana, Gambaryan, Alexandra, Katlinsky, Anton
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2008
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4634119/
https://www.ncbi.nlm.nih.gov/pubmed/19453396
http://dx.doi.org/10.1111/j.1750-2659.2008.00064.x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4634119/
https://www.ncbi.nlm.nih.gov/pubmed/19453396
http://dx.doi.org/10.1111/j.1750-2659.2008.00064.x

Ejemplares similares